NCT00704457View on ClinicalTrials.gov

Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2007

Conditions
Interstitial Cystitis
Trial Locations (1)

48073

Beaumont Hospital - Royal Oak, Royal Oak

All Listed Sponsors
collaborator

William Beaumont Hospitals

OTHER

lead

Kenneth Peters, MD

OTHER

NCT00704457 - Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC) | Biotech Hunter | Biotech Hunter